By Associate Professor Fatima Valdes Mora

Conference Papers

Jackson E; Duchatel R; Staudt D; Persson M; Mannan A; Yadavilli S; Parackal S; Game S; Chong WC; Jayasekara WS; Le Grand M; Kearney P; Douglas A; Findlay I; Germon Z; McEwen H; Beitaki T; Patabendige A; Skerrett-Byrne D; Nixon B; Smith N; Day B; Manoharan N; Nagabushan S; Hansford J; Govender D; McCowage G; Firestein R; Howlett M; Endersby R; Gottardo N; Alvaro F; Waszak S; Larsen M; Sanguino YC; Valdes-Mora F; Rakotomalala A; Meignan S; Pasquier E; Andre N; Hulleman E; Eisenstat D; Vitanza N; Nazarian J; Koschmann C; Mueller S; Cain J; Dun M, 2023, 'COMBINING ONC201 AND PAXALISIB FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA (DMG); THE PRECLINICAL RESULTS UNDERPINNING THE INTERNATIONAL PHASE II CLINICAL TRIAL (NCT05009992).', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, CANADA, Vancouver, presented at 28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO), CANADA, Vancouver, 15 November 2023 - 19 November 2023

Caderno PV; Awaysheh FM; Colino-Sanguino Y; Fuente LRDL; Valdes-Mora F; Cabaleiro JC; Pena TF; Gallego-Ortega D, 2023, 'OPERA-gSAM: Big Data Processing Framework for UMI Sequencing at High Scalability and Efficiency', in Proceedings 23rd IEEE ACM International Symposium on Cluster Cloud and Internet Computing Workshops Ccgridw 2023, pp. 160 - 167, http://dx.doi.org/10.1109/CCGridW59191.2023.00038

Persson M; Jackson E; Duchatel R; Bramberger L; McEwen H; Kearney P; Findlay I; Douglas A; Kobbe B; Wagener R; Larsen M; Faridi P; Holst J; Mayall J; Gedye C; Hondermarck H; Horvat J; Nixon B; Cartaxo R; Koschmann C; Valdes-Mora F; Ortega DG; Nazarian J; Alonso MM; Hulleman E; Van der Lugt J; Vitanza N; Mueller S; Dun M, 2022, 'ANTAGONISM OF DRD2 USING ONC201 INCREASED EXPRESSION OF ANTIGEN PRESENTATION PATHWAY PROTEINS IN DIFFUSE MIDLINE GLIOMA, RECRUITING TUMOR INFILTRATING LYMPHOCYTES IN VIVO', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, FL, Tampa, pp. 272 - 272, presented at 27th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO), FL, Tampa, 16 November 2022 - 20 November 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000888571001365&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ortega DG; Ledger A; Roden D; Cho C; Allerdice S; Lee H; Valdes-Mora F; Salomon R; Oakes S; Ormandy C, 2014, 'THE ETS TRANSCRIPTION FACTOR ELF5 IS A KEY DETERMINANT OF THE LETHAL PHENOTYPE IN LUMINAL BREAST CANCER, DRIVING THE ACQUISITION OF ANTIESTROGEN RESISTANCE AND METASTATIC ACTIVITY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 16 - 17, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Valdes-Mora F; Gomez del Pulgar T; Bandres E; Cejas P; Ramirez de Molina A; Perez-Palacios R; Gallego-Ortega D; Angel Garcia-Cabezas M; Garcia-Foncillas J; Carlos Lacal J, 2008, 'TWIST1 overexpression is associated with nodal invasion and male gender in primary colorectal cancer', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, FRANCE, Lyon, pp. 154 - 154, presented at 20th Meeting of the European-Association-for-Cancer-Research, FRANCE, Lyon, 05 July 2008 - 08 July 2008, http://dx.doi.org/10.1016/S1359-6349(08)71767-1

Back to profile page